Skip to content
MarketScale
‹ Back to IndustriesSciences

What the Acceleration of Smart Cities Looks Like Today

The COVID-19 pandemic has impacted city operations globally, influencing how residents commute, work, and live. Despite some infrastructure projects halting, interest in smart city technology continues. Keith Pennachio suggests COVID-19 may accelerate the adoption of technologies like fiber and contactless systems.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Daniel Litwin · Contactless PayDaniel Litwin VideoFiberInfrastructure
Share
What the Acceleration of Smart Cities Looks Like Today

Key takeaways

01

COVID-19 has accelerated interest in smart city technologies, especially those supporting contactless interactions.

02

Fiber infrastructure has seen growth despite some delays in building projects due to the pandemic.

03

Privacy concerns remain significant in the adoption of smart city technologies, requiring careful consideration.

The disruption of COVID is felt across the entire world. Cities feel this impact in many ways—how residents commute, work, dine, shop, and more. While the pandemic has ground to a halt some infrastructure projects in metro areas, the adoption of smart city technology is still of high interest. Telecom industry veteran Keith Pennachio, Chief Strategy Officer and EVP of SQUAN, shared his insights on COVID’s effect on smart cities. 

“There has been some slowdown in major cities, like New York, which shut down early. Some projects are on hold, mostly in building. But we’ve seen an increase in fiber. Overall, not a lot of delays in infrastructure,” Pennachio said. 

With a highly contagious virus, there has been a shift toward contactless. Smart cities could play a role in this, as well, and it may go beyond COVID. “We’ve seen a dramatic uptick in interest for equipment to facilitate contactless. Customers are asking, ‘How do I do this?’, and with fiber, more advanced technologies for contactless paying, devices in cards, or at front doors is possible,” Pennachio commented.

Will COVID leave permanent changes on how cities operate? Pennachio thinks yes, especially around things like temperature reading devices, already a fixture in Chinese and European international airports. They could become standard in the U.S. at airports, trains, and boats. 

So, what are the challenges of adopting a smart city architecture? One concern remains, privacy. Pennachio stated, “It’s a concern, not just at home when you’re using Alexa, but in general society. You should do your research before you opt-in and think about what the tradeoff is.”

The trend of smart cities isn’t waning, and Pennachio sees COVID as an accelerator. “Before COVID, some of these things were just an idea. Now there’s going to be more rapid adoption with drove and robot delivery,” he added. 

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

About the author

Daniel Litwin
Daniel LitwinEditor, B2B Media, MarketScale

Daniel Litwin is a journalist of multiple disciplines focused on finding and telling engaging stories for B2B communities. He has interviewed executives from Fortune 500 companies including Honeywell, Microsoft, John Deere, and Chipotle, and leads editorial direction at MarketScale. Litwin hosts weekly shows and podcasts while helping develop new content approaches across the MarketScale platform. He holds a B.J. in Radio/Television Reporting/Anchoring and a B.A. in Spanish from the University of Missouri-Columbia.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Sciences expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Sciences expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Myrias Optics taps photonics veteran Neil Anderson as CRO to scale flat optics into AI datacenters and AR

Myrias Optics taps photonics veteran Neil Anderson as CRO to scale flat optics into AI datacenters and AR

Myrias Optics has hired Neil Anderson, Ph.D. as the Chief Revenue Officer to spearhead the commercialization of its nanoimprint flat optics platform. The platform is intended for use in AI datacenters, augmented reality (AR), and life sciences applications. Anderson's experience in photonics is expected to aid Myrias Optics in expanding its market presence in these sectors.

  • 01Myrias Optics appointed Neil Anderson, Ph.D. as CRO to lead the commercialization of its technology.
  • 02The company focuses on nanoimprint flat optics for AI datacenters, AR, and life sciences.
  • 03Neil Anderson brings extensive photonics expertise to support Myrias Optics' growth.

Jul 31, 2026

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

The pharmaceutical industry is facing a significant challenge as over $300 billion in branded pharmaceutical revenue is set to lose patent protection by 2030. This revenue gap is driving the largest merger and acquisition cycle seen in a decade, with companies seeking external growth through acquisitions. This shift is impacting the entire life sciences supply chain, prompting strategic changes across the industry.

  • 01Over $300 billion in pharmaceutical revenue is at risk due to patent expirations by 2030.
  • 02Big Pharma is engaging in an aggressive cycle of mergers and acquisitions.
  • 03The acquisitions are reshaping the life sciences supply chain.

Jun 29, 2026

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences has initiated a Phase I clinical study at its UK facility for an oral solid dose formulation designed using artificial intelligence — what the company believes is the first AI-formulated drug to reach human clinical evaluation. The study, cleared by the UK's Medicines and Healthcare products Regulatory Agency, will assess safety and pharmacokinetics in healthy volunteers. The program, which used Intrepid Labs' machine learning algorithm, signals a broader shift in how contract drug development organizations are integrating AI across formulation and clinical workflows.

  • 01Quotient Sciences initiated a Phase I study of an AI-designed oral solid dose formulation at its UK facility following MHRA approval — the first such case the company believes has been reported.
  • 02The formulation was developed using Intrepid Labs' advanced machine learning algorithm in combination with Quotient Sciences' Translational Pharmaceutics platform.
  • 03The milestone is part of a broader CRDMO strategy to embed AI-enabled approaches across formulation development and clinical workflows, with implications for the wider contract pharma sector.

Jun 17, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Experts

Daniel Litwin
Daniel Litwin

Editor, B2B Media

MarketScale

Daniel Litwin is a journalist of multiple disciplines focused on finding and telling engaging stories for B2B communities. He has interviewed executives from Fortune 500 companies including Honeywell, Microsoft, John Deere, and Chipotle, and leads editorial direction at MarketScale. Litwin hosts weekly shows and podcasts while helping develop new content approaches across the MarketScale platform. He holds a B.J. in Radio/Television Reporting/Anchoring and a B.A. in Spanish from the University of Missouri-Columbia.

KP
Keith Pennachio

Chief Strategy Officer and EVP

SQUAN

Keith Pennachio is a telecom industry veteran with experience in driving strategy and executive leadership at SQUAN.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512